ConductScience.org, home

Paper40831701

Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations.

Liu W and 10 others. Front Cell Infect Microbiol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations. Papers, record 40831701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40831701

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Towards the elimination of infectious HPV: exploiting CRISPR/Cas innovations.
PubMed
Journal
Front Cell Infect Microbiol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-08-22
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu WWei
2Jiang YYingyan
3Wang CCheng
4Wang MMin
5Zhang WWei
6Ren HHaiying
7Xu SShiyan
8Qin JJinjing
9Liu PPan
10Jin LLianhai
11Zhao DDonghai

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CRISPR-Cas SystemsMajor topic
Papillomavirus InfectionsMajor topic
PapillomaviridaeMajor topic
Gene EditingMajor topic
Genetic TherapyMajor topic
Humans
Genome, Viral

Source PubMed

Download CSV of topics

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126422227Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.Cell2015https://conductscience.org/library/papers/26422227PubMed
236121194CRISPR/Cas9-HPV-liposome enhances antitumor immunity and treatment of HPV infection-associated cervical cancer.J Med Virol2023https://conductscience.org/library/papers/36121194PubMed
325031569Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis.Genomics Inform2014https://conductscience.org/library/papers/25031569PubMed
432243786CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.Cell2020https://conductscience.org/library/papers/32243786PubMed
526762611Role of Human Papillomavirus in Penile Carcinomas Worldwide.Eur Urol2016https://conductscience.org/library/papers/26762611PubMed
637403986Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice.J Med Virol2023https://conductscience.org/library/papers/37403986PubMed
732695664High-Risk HPV Oncoproteins and PD-1/PD-L1 Interplay in Human Cervical Cancer: Recent Evidence and Future Directions.Front Oncol2020https://conductscience.org/library/papers/32695664PubMed
828143725Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.Virus Res2017https://conductscience.org/library/papers/28143725PubMed
933277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
1030670702Engineering of CRISPR-Cas12b for human genome editing.Nat Commun2019https://conductscience.org/library/papers/30670702PubMed
1128798073The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.Clin Sci (Lond)2017https://conductscience.org/library/papers/28798073PubMed
1225136604Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.Biomed Res Int2014https://conductscience.org/library/papers/25136604PubMed
1321892917PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery.Curr Drug Metab2012https://conductscience.org/library/papers/21892917PubMed
1424817381Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.Int J Cancer2015https://conductscience.org/library/papers/24817381PubMed
1529215041CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.Sci Rep2017https://conductscience.org/library/papers/29215041PubMed
1624854633Identification and characterization of small molecule human papillomavirus E6 inhibitors.ACS Chem Biol2014https://conductscience.org/library/papers/24854633PubMed
1733432198Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice.Nat Biotechnol2021https://conductscience.org/library/papers/33432198PubMed
1812353208External genital warts: diagnosis, treatment, and prevention.Clin Infect Dis2002https://conductscience.org/library/papers/12353208PubMed
1925830891In vivo genome editing using Staphylococcus aureus Cas9.Nature2015https://conductscience.org/library/papers/25830891PubMed
2029704747Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.Biomaterials2018https://conductscience.org/library/papers/29704747PubMed

See all 92 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42798792CRISPR-Cas9 in Cancer Therapy: Overcoming Delivery Barriers and Off-Target Effects for Clinical Translation.Health Sci Rep2026https://conductscience.org/library/papers/42798792

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40831701

GET https://conductscience.org/api/papers/v1/40831701/references?page=2